Tag: Nanomedicine
-
Kurzweil forecast diamondoid respirocytes in bloodstreams by the 2020s. What arrived instead is a 1.8-millimeter magnetic microrobot entering human trials in 2026 — right direction, wrong scale by three orders of magnitude.
-
Kurzweil’s Bridge Three body upgrades are arriving — as peptide nanoparticles, silicon hemofilters, and insulin pumps, not diamondoid machines.
-
In 2005 Kurzweil named the decade, the substrate, and the architecture. In 2024 he quietly moved every date ten years. But the deeper question is whether ‘nanobot’ was the wrong word all along — and CRISPR, base editors, and LNPs are fulfilling the original vision in a body Kurzweil didn’t name.
-
Every mechanism Kurzweil predicted for 2010s nanomedicine has now worked in a human body at least once. The clinic still looks nothing like he drew.
-
Kurzweil’s press-a-button cancer kill arrived — just not through the mechanism he predicted. Respirocytes and microbivores remain on paper.
-
Twelve 2005 predictions on cell therapy, gene therapy, anti-amyloid vaccines, and diamondoid nanobots scored against 2026 clinical trials, patent filings, and approvals.